Specialty Pharma ApS: Financial statements 2019
CVR: 38476599
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Specialty Pharma ApS (CVR 38476599) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 819,270 and a net result of DKK -14,283 compared with DKK -1,875 the year before. That is an increase of 645.9% compared with the year before. Equity in the 2019 report amounted to DKK 56,373. The solvency ratio was 44.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 819,270
- Profit/Loss
- DKK -14,283
- Equity
- DKK 56,373
- Total Assets
- DKK 125,690
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 819 t. | -14 t. | 56 t. | 2 |
| 2018 | - | 110 t. | -2 t. | 71 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Specialty Pharma ApS has published its annual report for 2018. Gross profit came to DKK 109,840, and the net result was DKK -1,875.
About Specialty Pharma ApS
Specialty Pharma ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Ulla Haaning Singapuri. The company is owned by Ulla Haaning Singapuri. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 216,735 and a net result of DKK -58,566 compared with DKK -53,758 the year before. Equity in the 2025 report amounted to DKK -17,816.